- decreased eosinophil cell number / IMPC
- increased circulating phosphate level / IMPC
- increased bone mineral density / IMPC
- abnormal tooth morphology / IMPC
- abnormal gait / IMPC
- increased bone mineral content / IMPC
- increased red blood cell distribution width / IMPC
- abnormal vertebrae morphology / IMPC
- abnormal eyelid morphology / IMPC
- increased circulating cholesterol level / IMPC
- abnormal fibula morphology / IMPC
- abnormal locomotor behavior / IMPC
- increased circulating creatine kinase level / IMPC
- short tibia / IMPC
- decreased lymphocyte cell number / IMPC
- increased neutrophil cell number / IMPC
- increased total body fat amount / IMPC
- decreased lean body mass / IMPC
- abnormal femur morphology / IMPC
- decreased leukocyte cell number / IMPC
- abnormal rib morphology / IMPC
- abnormal maxilla morphology / IMPC
- abnormal radius morphology / IMPC
- abnormal zygomatic bone morphology / IMPC
- abnormal mandible morphology / IMPC
- abnormal humerus morphology / IMPC
- abnormal joint morphology / IMPC
- abnormal clavicle morphology / IMPC
- decreased circulating alkaline phosphatase level / IMPC
- increased circulating iron level / IMPC
- increased circulating aspartate transaminase level / IMPC
- abnormal ulna morphology / IMPC
- absent teeth / IMPC
- thrombocytopenia / IMPC
- abnormal snout morphology / IMPC
- abnormal tibia morphology / IMPC
- abnormal pelvic girdle bone morphology / IMPC
- increased circulating HDL cholesterol level / IMPC
C57BL/6N-Lrrk1tm1c(KOMP)Wtsi/H
| Status | Only small colony available |
| EMMA ID | EM:10149 |
| Citation information | RRID:IMSR_EM:10149 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | C57BL/6N-Lrrk1tm1c(KOMP)Wtsi/H |
| Alternative name | EPD0073_6_C01 |
| Strain type | Targeted Mutant Strains : Targeted Conditional |
| Allele/Transgene symbol | Lrrk1tm1c(KOMP)Wtsi |
| Gene/Transgene symbol | Lrrk1 |
| Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
| Provider | MRC, Medical Research Council |
| Provider affiliation | Mary Lyon Centre at MRC Harwell |
| Genetic information | This line originates from KOMP ES clone EPD0073_6_C01, after breeding with a Flp recombinase deleter line to convert the original targeted allele tm1a (knock-out first allele) into a conditional allele tm1c. For further details on the construction of this clone see the page at the IKMC page on the IMPC portal. |
| Phenotypic information | Potential phenotyping data in the IMPC portal |
| References | None available |
Information from EMMA
| Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Osteosclerotic metaphyseal dysplasia / Orphanet_500548
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- increased bone mineral density / MGI
- abnormal bone marrow cavity morphology / MGI
- osteopetrosis / MGI
- abnormal trabecular bone morphology / MGI
- abnormal long bone metaphysis morphology / MGI
- decreased body height / MGI
- abnormal osteoclast physiology / MGI
- short tibia / MGI
- abnormal bone mineralization / MGI
- decreased circulating alkaline phosphatase level / MGI
- short femur / MGI
- abnormal long bone morphology / MGI
- abnormal facial morphology / MGI
- increased compact bone thickness / MGI
- increased osteoclast cell number / MGI
- decreased bone resorption / MGI
- homeostasis/metabolism phenotype / MGI
- craniofacial phenotype / MGI
- skeleton phenotype / MGI
- osteosclerosis / MGI
- increased trabecular bone thickness / MGI
- increased bone trabecula number / MGI
- increased trabecular bone volume / MGI
- preweaning lethality, incomplete penetrance / MGI
- decreased susceptibility to osteoporosis / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).
